-
2 weeks ago | 
healio.com | Andrew Rhoades |Stephanie Viguers |Angela Fitch
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
Jul 30, 2024 | 
msn.com | Angela Fitch
Continue reading More for You
-
Jul 30, 2024 | 
finance.yahoo.com | Angela Fitch
Angela FitchTue, Jul 30, 2024, 11:23 AM5 min readFor as long as I can remember, obesity has affected me and my family. From my father to my brother and even five generations before that, the disease was in our DNA—starting in childhood for some and later in life for others. Obesity met me in med school, and not just on the pages of my textbooks. My routine was flipped upside down, and I was all of a sudden struggling with my weight and overall health.
-
Jul 9, 2024 | 
verywellhealth.com | Angela Fitch
-
Jun 11, 2024 | 
bottomlineinc.com | Angela Fitch
GLP-1 receptor agonists can slash your appetite so dramatically that you could go all day without the drive to eat or drink. But your body still needs enough calories to keep your processes humming. Protein, especially, is crucial for preventing muscle loss. (Over time, loss of muscle mass impacts strength, metabolism, mobility, immune function and wound healing.) You need 1 gram (g) to 1.5 g of protein per kilogram of body weight per day.
-
May 28, 2024 | 
psychiatryadvisor.com | Anastasia Climan |Jamy Ard |Angela Fitch |Joe Nadglowski
Compassion Fatigue: What to Do When Care Becomes Overwhelming Endocrinology Advisor Opinion: Clinical Drug Trials Must Represent All Weight Statuses Doctors’ Orders: Mental Health Resources Developed by Physicians, for Physicians COVID-19 Vaccine Updates: mRNA Advancements and Coadministration Guidelines Extreme Heat Is Particularly Hard on Older Adults – An Aging Population and Climate Change Clinical Tools Powered by
-
Apr 25, 2024 | 
healio.com | Angela Fitch |Andrew Rhoades |Stephanie Viguers
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DENVER — More than 1,200 clinicians are coming together to learn more about obesity at the Obesity Medicine Association’s 2024 conference, according to a speaker here.
-
Apr 18, 2024 | 
healio.com | John Schoen |Angela Fitch |Carol L. DiBerardino
You've successfully added Obesity in Primary Care to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:The Obesity Medicine Association will host its annual meeting in Denver, April 24-28. About 1,300 clinicians and students will be in attendance, according to the OMA president.
-
Feb 9, 2024 | 
verywellhealth.com | Claire Bugos |Angela Fitch
Tirzepatide, known as Zepbound and Mounjaro, can reduce blood pressure by more than 7.4 mm Hg, according to a new study. The study group only included people who have normal blood pressure. It’s not yet clear what the effect will be in people with uncontrolled hypertension. The new data adds to the growing evidence that treating obesity with drugs can improve heart health and other health outcomes.
-
Jan 26, 2024 | 
psychiatryadvisor.com | Jamy Ard |Angela Fitch |Joe Nadglowski
Disclaimer: This article was written by Jamy Ard, MD, Angela Fitch, MD, and Joe Nadglowski in their personal capacities. The opinions expressed in this article are their own and do not necessarily reflect the views of Endocrinology Advisor or Haymarket Media. The landscape of health care is constantly evolving, and with it, the need for inclusivity in drug trials becomes increasingly evident.
